This Department of Defense (CFDA 12.420 - Military Medical Research and Development) Project Grant award of $2,499,990.00 was provided to the Dartmouth-Hitchcock Clinic, doing business as Dartmouth-Hitchcock Obligated Group, to conduct a multicenter randomized controlled trial evaluating the use of incisional negative pressure wound therapy to reduce infection and complications in high-risk fractures. The grant has an award date of September 1, 2023 and an ultimate completion date of August 31, 2027. As a leading academic medical center focused on rural healthcare, Dartmouth-Hitchcock has extensive experience conducting federally-funded medical research and clinical trials across various healthcare disciplines. This grant award will support their efforts to advance knowledge and improve clinical outcomes related to wound management for patients with high-risk fractures.
Generated 8/13/24, 8:01 AM